##' Warfarin PK/PD data
##'
##' @format A data frame with 519 rows and 9 columns
##'
##' \describe{
##' \item{id}{Patient identifier (n=32)}
##' \item{time}{Time (h)}
##' \item{amt}{Total drug administered (mg)}
##' \item{dv}{Warfarin concentrations (mg/L) or PCA measurement}
##' \item{dvid}{Dependent identifier Information (cp: Dose or PK, pca: PCA, factor)}
##' \item{evid}{Event identifier}
##' \item{wt}{Weight (kg)}
##' \item{age}{Age (yr)}
##' \item{sex}{Sex (male or female, factor)}
##' }
##'
##' @source Funaki T, Holford N, Fujita S (2018). Population PKPD
##' analysis using nlmixr2 and NONMEM. PAGJA 2018
##'
##' @references
##'
##' O'Reilly RA, Aggeler PM, Leong LS. Studies of the coumarin
##' anticoagulant drugs: The pharmacodynamics of warfarin in man.
##' Journal of Clinical Investigation 1963; 42(10): 1542-1551
##'
##' O'Reilly RA, Aggeler PM. Studies on coumarin anticoagulant drugs
##' Initiation of warfarin therapy without a loading dose. Circulation
##' 1968; 38: 169-177.
##'
##' @family nlmixr2 datasets
"warfarin"
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.